Jay Piccirillo

Medicine & Life Sciences

1. Tinnitus 100%
2. Comorbidity 76%
3. Head and Neck Neoplasms 74%
4. Sino-Nasal Outcome Test 48%
5. Survival 45%
6. Squamous Cell Carcinoma 42%
7. Sinusitis 40%
8. Health Care Outcome Assessment 39%
9. Neoplasms 31%
10. Otolaryngology 27%
11. Arnold-Chiari Malformation 26%
12. Randomized Controlled Trials 26%
13. Central Nervous System Vascular Malformations 25%
14. Therapeutics 24%
15. Neck 22%
16. Hereditary Hemorrhagic Telangiectasia 21%
17. Head 20%
18. Laryngeal Neoplasms 19%
19. Quality of Life 17%
20. Databases 16%
21. Confidence Intervals 16%
22. Squamous Cell Carcinoma of Head and Neck 15%
23. Obstructive Sleep Apnea 15%
24. Neoplasm Staging 15%
25. Survival Rate 15%
26. Smell 14%
27. Ecological Momentary Assessment 14%
28. Epidemiology 14%
29. Odds Ratio 14%
30. Nasal Lavage 14%
31. Recurrence 13%
32. Placebos 13%
33. Radiotherapy 12%
34. Guidelines 12%
35. Nasal Polyps 12%
36. Drug Therapy 12%
37. Hearing Loss 12%
38. Mouth 11%
39. Nose 11%
40. Oropharyngeal Neoplasms 11%
41. Cohort Studies 11%
42. Second Primary Neoplasms 11%
43. Sleep Apnea Syndromes 10%
44. Psychometrics 10%
45. Mortality 10%
46. Medicare 10%
47. Oropharynx 9%
48. Dizziness 9%
49. Transcranial Magnetic Stimulation 9%
50. Tongue 9%